Back to today’s briefing

Story perspectives

OpenEvidence Raises $250M, Doubles Valuation to $12B

1/21/2026

25 4 Full Breakdown

Summary

Story summary

OpenEvidence, a Miami-based AI startup, raised $250 million in a Series D, doubling its valuation to $12 billion.
OpenEvidence was founded in 2022 by Daniel Nadler and Zachary Ziegler and develops AI-powered tools for doctors using data from top medical journals.
The company says more than 100 million Americans were treated using its platform last year, and it has raised nearly $700 million overall with $100 million in annual revenue.

History

Historical Context

The COVID-19 pandemic accelerated telehealth adoption in the U.S. healthcare sector, with companies like Teladoc Health reporting a 200% increase in virtual visits in 2021. Founded in 2022, OpenEvidence aims to enhance medical practices through AI, raising $250 million to support its platform that assists over 430,000 physicians. This shift signifies a transformative trend in patient care and healthcare delivery.

1 of 2

Story summary

OpenEvidence, a Miami-based AI startup, raised $250 million in a Series D, doubling its valuation to $12 billion.
OpenEvidence was founded in 2022 by Daniel Nadler and Zachary Ziegler and develops AI-powered tools for doctors using data from top medical journals.
The company says more than 100 million Americans were treated using its platform last year, and it has raised nearly $700 million overall with $100 million in annual revenue.

1 / 2